摘要:
The invention describes new solvates of lercanidipine hydrochloride with organic solvents, new crystalline Forms (III) and (IV) of lercanidipine hydrochloride obtained from said solvates by removing solvation solvents, and pharmaceutical compositions containing as active agent at least one of the crystalline Forms (III) and (IV) of lercanidipine hydrochloride.
摘要:
The invention describes novel lercanidipine crude Forms (A) and (B), novel lercanidipine hydrochloride crystalline Forms (I) and (II) obtained form said crude Forms, pharmaceutical, antihypertensive compositions containing as active agent at least one of the lercanidipine hydrochloride crystalline Forms (I) and (II) and methods of use thereof
摘要:
The invention describes new solvates of lercanidipine hydrochloride with organic solvents, new crystalline Forms (III) and (IV) of lercanidipine hydrochloride obtained from said solvates by removing solvation solvents, and pharmaceutical compositions containing as active agent at least one of the crystalline Forms (III) and (IV) of lercanidipine hydrochloride.
摘要:
The invention describes novel lercanidipine crude Forms (A) and (B), novel lercanidipine hydrochloride crystalline Forms (I) and (II) obtained form said crude Forms, pharmaceutical, antihypertensive compositions containing as active agent at least one of the lercanidipine hydrochloride crystalline Forms (I) and (II) and methods of use thereof
摘要:
The invention describes novel lercanidipine crude Forms (A) and (B), novel lercanidipine hydrochloride crystalline Forms (I) and (II) obtained form said crude Forms, pharmaceutical, antihypertensive compositions containing as active agent at least one of the lercanidipine hydrochloride crystalline Forms (I) and (II) and methods of use thereof